Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Novo Nordisk Dives 9%. Why Eli Lilly Now Has The Upper Hand.
In This Article:
Novo Nordisk stock tumbled Monday after its experimental weight-loss drug failed to top its rival from Eli Lilly in a Phase 3 study.